Legend Biotech Usa Inc
Clinical trials sponsored by Legend Biotech Usa Inc, explained in plain language.
-
Engineered immune cells take on Hard-to-Treat digestive cancers
Disease control OngoingThis early-phase trial tests a new treatment called LB1908, which uses a patient's own immune cells (T-cells) engineered to recognize and attack cancer cells that have a protein called claudin 18.2 on their surface. The study includes adults with advanced stomach, gastroesophagea…
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Engineered immune cells take aim at tough lung cancer
Disease control OngoingThis early-stage trial tests a new treatment called LB2102, which uses a patient's own immune cells (T-cells) that have been modified to recognize and attack cancer cells that have a specific marker (DLL3). The study includes about 41 adults with advanced small cell lung cancer o…
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 04, 2026 16:31 UTC